Clinical Trial Update: Effects of Dexmedetomidine on Delirium Duration of Non-intubated ICU Patients (4D Trial) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the effects of dexmedetomidine on delirium duration in non-intubated ICU patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Delirium, Agitation | Phase 3 | Status: COMPLETED